Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-y (IFN-y) in experimental infection with Listeria Monocytogenes
- 1 June 1993
- journal article
- research article
- Published by Springer Nature in Biotherapy
- Vol. 6 (2) , 113-124
- https://doi.org/10.1007/bf01877424
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Immunotherapy of Murine Visceral Leishmaniasis with Murine Recombinant Interferon-γ and MTP-PE Encapsulated in LiposomesJournal of Interferon Research, 1991
- Antiviral and Antiproliferative Properties of Liposome-Associated Human Interferon-αJournal of Interferon Research, 1990
- Effect of murine recombinant interferon-γ in the protection of mice against salmonellaInternational Journal of Immunopharmacology, 1990
- Immunological effects of recombinant interferon gamma in vivo in normal mice: failure to induce autoantibodiesInternational Journal of Immunopharmacology, 1990
- Mouse Interferon-γ in Liposomes: Pharmacokinetics, Organ-Distribution, and Activation of Spleen and Liver MacrophagesIn VivoJournal of Interferon Research, 1989
- Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or -interferonJournal of Medical Microbiology, 1989
- Enhanced killing of Blastomyces dermatitidis by gamma interferon-activated murine peripheral blood polymorphonuclear neutrophilsInternational Journal of Immunopharmacology, 1989
- Activation of murine kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptideHepatology, 1988
- The potential use of liposome-mediated antiviral therapyAntiviral Research, 1985
- Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferonEuropean Journal of Immunology, 1984